Literature DB >> 12902416

Cholecystokinin cholescintigraphy: methodology and normal values using a lactose-free fatty-meal food supplement.

Harvey A Ziessman1, Douglas A Jones, Larry R Muenz, Anup K Agarval.   

Abstract

UNLABELLED: The purpose of this investigation was to evaluate the use of a commercially available lactose-free fatty-meal food supplement, as an alternative to sincalide cholescintigraphy, to develop a standard methodology, and to determine normal gallbladder ejection fractions (GBEFs) for this supplement.
METHODS: Twenty healthy volunteers all had negative medical histories for hepatobiliary and gallbladder disease, had no personal or family history of hepatobiliary disease, and were not taking any medication known to affect gallbladder emptying. All were prescreened with a complete blood cell count, comprehensive metabolic profile, gallbladder and liver ultrasonography, and conventional cholescintigraphy. Three of the 20 subjects were eliminated from the final analysis because of an abnormality in one of the above studies.
RESULTS: After gallbladder filling on conventional cholescintigraphy, the subjects ingested the supplement and an additional 60-min study was acquired. GBEFs were calculated and ranged from 33% to 95% (mean +/- SD, 62.6% +/- 21.3%). Statistical analysis determined the lower range of normal to be 32.6%. Maximal gallbladder emptying occurred between 55 and 60 min.
CONCLUSION: A standard methodology and normal GBEFs (> or =33%) were established for supplement-stimulated cholescintigraphy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902416

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  Gallbladder dysfunction diagnosed by cholescintigraphy with a Fatty meal.

Authors:  Akira Hokama; Kazuto Kishimoto; Yasushi Ihama; Hiroshi Chinen; Fukunori Kinjo; Jiro Fujita
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

2.  Use of Entero-Test, a simple approach for non-invasive clinical evaluation of the biliary disposition of drugs.

Authors:  William J Guiney; Claire Beaumont; Steve R Thomas; Darren C Robertson; Simon M McHugh; Annelize Koch; Duncan Richards
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

3.  HIDA scan ejection fraction does not predict sphincter of Oddi hypertension or clinical outcome in patients with suspected chronic acalculous cholecystitis.

Authors:  S B Young; M Arregui; K Singh
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

4.  Reproducibility of gallbladder ejection fraction measured by Fatty meal cholescintigraphy.

Authors:  Kusai M Al-Muqbel; Mohammed N Bani Hani; Mwaffaq A Elheis; Ma'moon H Al-Omari
Journal:  Nucl Med Mol Imaging       Date:  2010-10-13

5.  Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.

Authors:  Cristian C Constantinescu; Cedric Tresse; MingQiang Zheng; Alexandra Gouasmat; Vincent M Carroll; Laetitia Mistico; David Alagille; Christine M Sandiego; Caroline Papin; Kenneth Marek; John P Seibyl; Gilles D Tamagnan; Olivier Barret
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

6.  Right upper quadrant pain with normal hepatobiliary ultrasound: can hepatobiliary scintigraphy define the cause?

Authors:  Saleh A Othman
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

7.  Standardization of "In-House fatty meal" methodology for cholescintigraphy.

Authors:  Avani S Jain; Shelley Simon; Indirani Muthukrishnan; A T Mohan; Ramakrishnan Balsubramaniam
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

8.  Fatty meal ultrasonography in chronic acalculous cholecystitis.

Authors:  Anna Donen; Robin Kantor
Journal:  J Surg Case Rep       Date:  2014-11-18

9.  Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride.

Authors:  Robert K Doot; Jacob G Dubroff; Joshua S Scheuermann; Kyle J Labban; Jenny Cai; Chia-Ju Hsieh; Shihong Li; Hsiaoju Lee; Erin K Schubert; Catherine Hou; Regan Sheffer; Alexander Schmitz; Kuiying Xu; Robert H Mach
Journal:  EJNMMI Phys       Date:  2018-10-08

10.  Improving Hepatobiliary Imaging as a Physiologic Test with Superior Clinical Outcomes.

Authors:  Isis W Gayed; Lydia Dawood; Zhang Xu; Grace Rizk; Andrew Dupont; Monica Atta; Emily K Robinson
Journal:  World J Nucl Med       Date:  2020-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.